Virion Therapeutics Reports Positive Clinical Data with VRON-0200, a Novel Checkpoint Modifier for HBV Functional Cure, at APASL 2025 Global Liver Meeting
Hand-out
Press Releases
Virion Therapeutics, LLC  
March 28, 2025

Virion Therapeutics Reports Positive Clinical Data with VRON-0200, a Novel Checkpoint Modifier for HBV Functional Cure, at APASL 2025 Global Liver Meeting

Highlights from the Data Presentation

logo salamanca press

Salamanca Press

Local & Social